Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Impaired cell-mediated immunity function in thyroid cancer

K Y Liaw, Y Chang-Chien, Y C Chen

    Cancer
    |July 15, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    IgG4 as the predominant IgG subclass in pemphigoides gestationis.

    Journal of cutaneous pathology·2006
    Same author

    Anti-adenosine deaminase antibodies in lupus erythematosus.

    Lupus·2002
    Same author

    The relationship between structures and in vitro properties of a polyanhydride implant containing gentamicin sulfate.

    Pharmaceutical development and technology·2002
    Same author

    Superoxide dismutase in hepatocellular carcinoma affects patient prognosis.

    Hepato-gastroenterology·2001
    Same author

    The cell-surface-expressed nucleolin is associated with the actin cytoskeleton.

    Experimental cell research·2000
    Same author

    Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue.

    Thyroid : official journal of the American Thyroid Association·1999

    Thyroid cancer patients show normal immunoglobulin and T-cell counts, but impaired cell-mediated immunity. This immune dysfunction, indicated by reduced lymphocyte blastogenesis and skin test responses, is more pronounced with larger tumors or metastasis.

    Area of Science:

    • Immunology
    • Oncology
    • Cellular Biology

    Background:

    • Thyroid cancer impacts various bodily systems, including the immune system.
    • Understanding immune status in thyroid cancer patients is crucial for prognosis and treatment.
    • Previous studies have yielded mixed results on immune cell function in thyroid cancer.

    Purpose of the Study:

    • To investigate immunological parameters in patients with thyroid cancer.
    • To assess T-cell and B-cell percentages, immunoglobulin levels, and cell-mediated immunity.
    • To correlate immune function with clinical factors like tumor size, metastasis, and age.

    Main Methods:

    • Studied 31 thyroid cancer patients and a control group.
    • Measured serum immunoglobulin levels and peripheral blood T/B cell percentages.

    Related Experiment Videos

  • Assessed lymphocyte blastogenesis using phytohemagglutinin P (PHA).
  • Evaluated cell-mediated immunity via skin tests with purified-protein-derivative (PPD) and Streptokinase-Streptodornase (SK-SD).

    • Main Results:

    • No significant differences in immunoglobulin levels or T/B cell percentages compared to controls.
    • Significantly reduced lymphocyte blastogenesis (PHA response), particularly in patients with larger tumors, metastasis, or over age 60.
    • Markedly reduced positive rates for PPD and SK-SD skin tests.

    Conclusions:

    • Thyroid cancer patients exhibit impaired cell-mediated immunity despite normal T-cell counts.
    • Reduced lymphocyte blastogenesis and skin test reactivity indicate functional immune deficits.
    • These findings suggest a compromised cellular immune response in thyroid cancer, influenced by tumor burden and patient age.